An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity

Baseline susceptibility of primary HIV-2 to entry inhibitors

(2012) Pedro Borrego et al.   ANTIVIRAL THERAPY

Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance

(2011) M. E. S. Sampah et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41

(2010) Lifeng Cai et al.   ChemMedChem

Inhibition of HIV-1 by Fusion Inhibitors

(2010) Dirk Eggink et al.   CURRENT PHARMACEUTICAL DESIGN

Detailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion Inhibitors

(2009) Dirk Eggink et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The history of antiretrovirals: key discoveries over the past 25 years

(2009) Erik De Clercq   REVIEWS IN MEDICAL VIROLOGY

SC29EK, a Peptide Fusion Inhibitor with Enhanced  -Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide

(2008) T. Naito et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil

(2008) Kelly Champagne et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor

(2008) Yuxian He et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20

(2008) Kazuki Izumi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research

(2008) Y. Takeuchi et al.   JOURNAL OF VIROLOGY

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

(2008) Lin Shen et al.   NATURE MEDICINE

HIV-2: the forgotten AIDS virus

(2008) Thushan I. de Silva et al.   TRENDS IN MICROBIOLOGY